Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular melanoma.

J C Cather1, J C Cather, C N Soparkar

  • 1Department of Dermatology, University of Texas Health Science Center at Houston, USA.

Cutis
|June 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.

The British journal of dermatology·2018
Same author

Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Ophthalmological outcome following orbital resection in anterior and anterolateral skull base surgery.

Neurosurgical focus·2006
Same author

Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity.

Clinical lymphoma·2001
Same author

Perineural invasion of cutaneous malignancies.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2001
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
Same journal

A Simple Alternative for Intralesional Cryosurgery of Keloids and Hypertrophic Scars Using a Disposable Infusion Set.

Cutis·2026
Same journal

A Guide to Avoiding Common Procedural Coding Mistakes.

Cutis·2026
Same journal

Dermatology Boards Demystified: Conquer the BASIC, CORE, and APPLIED Exams.

Cutis·2026
See all related articles

Ocular melanoma, the second most common primary melanoma, requires prompt diagnosis. Early detection and ophthalmologic screening are crucial for effective treatment and improved patient outcomes in melanoma cases.

Area of Science:

  • Ophthalmology
  • Oncology
  • Dermatology

Background:

  • The eye is the second most frequent site for primary melanoma.
  • Ophthalmologic evaluation is often overlooked in general melanoma screening protocols.
  • Delayed diagnosis of ocular melanoma can lead to severe consequences and poor prognosis.

Purpose of the Study:

  • To emphasize the importance of ophthalmologic evaluation in melanoma screening.
  • To raise clinical awareness among physicians regarding ocular melanoma.
  • To highlight the benefits of early recognition and diagnosis for treatment and cure.

Main Methods:

  • This article is a review and clinical awareness piece.
  • It synthesizes current understanding of ocular melanoma diagnosis and management.

Related Experiment Videos

  • It stresses the need for physician education and appropriate patient referral.

    • Main Results:

    • Early diagnosis of ocular melanoma significantly improves prognosis.
    • Timely interventional treatments can lead to complete cures.
    • Integrating ocular screening into routine melanoma checks is vital.

    Conclusions:

    • Physicians must understand and implement ocular melanoma screening.
    • Appropriate examination or referral for suspected ocular melanoma is imperative.
    • Routine screening can prevent advanced disease and improve patient survival rates.